-
Research,
Translational Medicine
Four promising projects aim to discover which patients will experience benefits or toxicity.
Perlmutter Cancer Center Highlights, Perlmutter Cancer Center Highlights 2019–2020
-
Research,
Translational Medicine
These phase 2 trials provide new options for treating glioblastomas and meningiomas.
Perlmutter Cancer Center Highlights, Perlmutter Cancer Center Highlights 2019–2020
-
Research,
Translational Medicine
Dozens of trials explore a wide variety of drug strategies and tumor types.
Perlmutter Cancer Center Highlights, Perlmutter Cancer Center Highlights 2019–2020
-
Research,
Patient Care
New programs are changing how individuals are screened for genetic risk for cancer.
Perlmutter Cancer Center Highlights, Perlmutter Cancer Center Highlights 2019–2020
-
Research,
Patient Care
Studies show decreases in postoperative morbidity, pain, and recovery time compared with thoracotomy.
Perlmutter Cancer Center Highlights, Perlmutter Cancer Center Highlights 2019–2020
-
Research,
Patient Care
Clinicians, researchers, and patients work together to increase 5-year survival rate to 50 percent.
Perlmutter Cancer Center Highlights, Perlmutter Cancer Center Highlights 2019–2020
